-
Mashup Score: 0
A new survey revealed that 64% of clinicians feel physically unsafe at work. The perceived risk of violence was especially high among women, clinicians under age 40, emergency department physicians and employees who work with patients struggling with addiction or other mental health conditions.
Source: MedCity NewsCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Pfizer, Flagship Team Up in $100M R&D Pact: 10 New Drugs for Unmet Needs - MedCity News - 9 month(s) ago
Pfizer and Flagship Pioneering are partnering in a drug research alliance leveraging the capabilities of the more than 40 biotech startups in the venture capital firm’s portfolio. The new partners aim to develop drugs for unmet needs, including those in broad patient populations.
Source: MedCity NewsCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0What Misconceptions Does the Healthcare Industry Still Have About Home-Based Care? - MedCity News - 9 month(s) ago
The at-home care field holds significant market potential. As the subsector continues to grow, some leaders of home healthcare startups are challenging misconceptions that some other industry stakeholders may still have, including the misbelief that at-home care is only for senior citizens and that this care model lacks scalability.
Source: MedCity NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Report: 10 Prescription Drugs Took Up 22% of Medicare Part D Spending in 2021 - MedCity News - 9 month(s) ago
KFF found that the 10 top-selling Part D drugs represented $47.7 billion of the $215.7 billion total gross Medicare Part D drug spending in 2021. Eliquis, a blood thinner by Bristol Myers Squibb, accounted for the most spending out of these 10 drugs at $12.6 billion.
Source: MedCity NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0An AI-Enabled Approach to Improve Access to Physical Therapy for Self-Insured Employers - MedCity News - 9 month(s) ago
Quantum Health has bolstered its collaboration with Sword Health by integrating MSK services to members to track home exercise, avoid unnecessary surgery and support treatment of pelvic conditions.
Source: MedCity NewsCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Advice Given by ChatGPT Vs. Human Providers Is Nearly Indistinguishable, NYU Study Says - MedCity News - 9 month(s) ago
NYU researchers conducted a study this year in which nearly 400 people were asked to identify whether responses to patient questions were produced by human providers or ChatGPT. Participants had a limited ability to tell the source of the responses apart, so the study authors concluded that the use of LLMs like ChatGPT could be an effective way to streamline healthcare providers’ communication…
Source: MedCity NewsCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1FDA Approval of RSV Drug Gives Infants and Toddlers Long-Lasting Protection - MedCity News - 9 month(s) ago
AstraZeneca and Sanofi drug Beyfortus is now FDA approved for preventing respiratory problems from RSV infection in infants and toddlers. Antibody engineering enables the drug to last longer in the body, providing protective effects for potentially the entire RSV season.
Source: MedCity NewsCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Prominence Health Medicare Advantage enrollees will have 24/7 access to Strive Health’s specialized care team through a new partnership. Strive Health is also teaming up with Sierra Nevada Specialty Care, a local nephrology clinic in Nevada.
Source: MedCity NewsCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Kraft Heinz recently sued Aetna, claiming that the insurer is not providing all of Kraft Heinz’s medical claims data. More lawsuits of this sort are likely to come, experts warned.
Source: MedCity NewsCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Eli Lilly Strengthens the Case for Going Early in Alzheimer’s Treatment - MedCity News - 9 month(s) ago
Alzheimer’s disease patients in the earliest stages of their disease benefited the most benefit from Eli Lilly drug donanemab, which is expected to receive an FDA decision by the end of 2023. Full results from the drug’s pivotal study were presented during the during the Alzheimer’s Association International Conference.
Source: MedCity NewsCategories: General Medicine News, Latest HeadlinesTweet
A new survey revealed that 64% of clinicians feel physically unsafe at work. The perceived risk of violence was especially high among women, clinicians under age 40, emergency department physicians and employees who work with patients struggling with... https://t.co/0JQvibhAi2